SE9904475D0 - Nucleic acid delivery system - Google Patents
Nucleic acid delivery systemInfo
- Publication number
- SE9904475D0 SE9904475D0 SE9904475A SE9904475A SE9904475D0 SE 9904475 D0 SE9904475 D0 SE 9904475D0 SE 9904475 A SE9904475 A SE 9904475A SE 9904475 A SE9904475 A SE 9904475A SE 9904475 D0 SE9904475 D0 SE 9904475D0
- Authority
- SE
- Sweden
- Prior art keywords
- composition
- nucleic acids
- delivery system
- nucleic acid
- acid delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904475A SE9904475D0 (sv) | 1999-12-08 | 1999-12-08 | Nucleic acid delivery system |
EP00981347A EP1235597A2 (en) | 1999-12-08 | 2000-12-07 | Nucleic acid delivery system |
PCT/EP2000/012339 WO2001041810A2 (en) | 1999-12-08 | 2000-12-07 | Nucleic acid delivery system |
CA002393526A CA2393526A1 (en) | 1999-12-08 | 2000-12-07 | Nucleic acid delivery system |
US10/149,458 US20030166594A1 (en) | 1999-12-08 | 2000-12-07 | Nucleic acid delivery system |
MXPA02005697A MXPA02005697A (es) | 1999-12-08 | 2000-12-07 | Sistema de suministro de acido nucleico. |
AU18621/01A AU782370B2 (en) | 1999-12-08 | 2000-12-07 | Nucleic acid delivery system |
JP2001543154A JP2003516365A (ja) | 1999-12-08 | 2000-12-07 | 核酸送達系 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904475A SE9904475D0 (sv) | 1999-12-08 | 1999-12-08 | Nucleic acid delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9904475D0 true SE9904475D0 (sv) | 1999-12-08 |
Family
ID=20418034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9904475A SE9904475D0 (sv) | 1999-12-08 | 1999-12-08 | Nucleic acid delivery system |
Country Status (2)
Country | Link |
---|---|
US (1) | US20030166594A1 (sv) |
SE (1) | SE9904475D0 (sv) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7935517B2 (en) * | 2004-09-22 | 2011-05-03 | Nanolab, Inc. | Nanospearing for molecular transportation into cells |
WO2006116065A1 (en) * | 2005-04-21 | 2006-11-02 | The Trustees Of Boston College | Methods for molecular delivery into cells using nanotube spearing |
US20060257355A1 (en) * | 2005-05-10 | 2006-11-16 | Abiomed, Inc. | Impregnated polymer compositions and devices using them |
US20070104689A1 (en) * | 2005-09-27 | 2007-05-10 | Merck Patent Gmbh | Compositions and methods for treating tumors presenting survivin antigens |
US7875449B2 (en) * | 2006-09-15 | 2011-01-25 | Fmc Biopolymer As | Oligonucleotide non-viral delivery systems |
US9060926B2 (en) | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US9060934B2 (en) | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8788211B2 (en) | 2008-10-31 | 2014-07-22 | The Invention Science Fund I, Llc | Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition |
US20100111857A1 (en) | 2008-10-31 | 2010-05-06 | Boyden Edward S | Compositions and methods for surface abrasion with frozen particles |
US8721583B2 (en) | 2008-10-31 | 2014-05-13 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8731841B2 (en) | 2008-10-31 | 2014-05-20 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8545856B2 (en) | 2008-10-31 | 2013-10-01 | The Invention Science Fund I, Llc | Compositions and methods for delivery of frozen particle adhesives |
US8409376B2 (en) | 2008-10-31 | 2013-04-02 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8545855B2 (en) | 2008-10-31 | 2013-10-01 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US9060931B2 (en) | 2008-10-31 | 2015-06-23 | The Invention Science Fund I, Llc | Compositions and methods for delivery of frozen particle adhesives |
US8793075B2 (en) | 2008-10-31 | 2014-07-29 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US9050317B2 (en) | 2008-10-31 | 2015-06-09 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8762067B2 (en) | 2008-10-31 | 2014-06-24 | The Invention Science Fund I, Llc | Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data |
US9072799B2 (en) | 2008-10-31 | 2015-07-07 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US9040087B2 (en) | 2008-10-31 | 2015-05-26 | The Invention Science Fund I, Llc | Frozen compositions and methods for piercing a substrate |
US8603496B2 (en) | 2008-10-31 | 2013-12-10 | The Invention Science Fund I, Llc | Compositions and methods for biological remodeling with frozen particle compositions |
US8551505B2 (en) | 2008-10-31 | 2013-10-08 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US8725420B2 (en) | 2008-10-31 | 2014-05-13 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8603495B2 (en) | 2008-10-31 | 2013-12-10 | The Invention Science Fund I, Llc | Compositions and methods for biological remodeling with frozen particle compositions |
US8563012B2 (en) | 2008-10-31 | 2013-10-22 | The Invention Science Fund I, Llc | Compositions and methods for administering compartmentalized frozen particles |
US8603494B2 (en) | 2008-10-31 | 2013-12-10 | The Invention Science Fund I, Llc | Compositions and methods for administering compartmentalized frozen particles |
US9072688B2 (en) * | 2008-10-31 | 2015-07-07 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
US9050070B2 (en) | 2008-10-31 | 2015-06-09 | The Invention Science Fund I, Llc | Compositions and methods for surface abrasion with frozen particles |
US8518031B2 (en) | 2008-10-31 | 2013-08-27 | The Invention Science Fund I, Llc | Systems, devices and methods for making or administering frozen particles |
US8731840B2 (en) | 2008-10-31 | 2014-05-20 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with frozen particles |
AU2010338349B2 (en) * | 2009-12-29 | 2015-03-05 | Global Life Sciences Solutions Usa Llc | Improvements to nucleic acid elution |
AU2013209620B2 (en) * | 2012-01-19 | 2017-06-15 | Merck Millipore Ltd. | Chromatographic media for storage and delivery of therapeutic biologics and small molecules |
US10566740B2 (en) | 2018-03-29 | 2020-02-18 | Te Connectivity Corporation | Shielding structure for a contact module of an electrical connector |
CN109125247A (zh) * | 2018-09-06 | 2019-01-04 | 广州苿莱生物科技有限公司 | 成体干细胞冻干粉的制备方法及其在化妆品中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3146168A (en) * | 1962-04-10 | 1964-08-25 | Fmc Corp | Manufacture of pharmaceutical preparations containing cellulose crystallite aggregates |
US4063017A (en) * | 1976-04-22 | 1977-12-13 | Purdue Research Foundation | Porous cellulose beads and the immobilization of enzymes therewith |
US6743779B1 (en) * | 1994-11-29 | 2004-06-01 | Imarx Pharmaceutical Corp. | Methods for delivering compounds into a cell |
US6060246A (en) * | 1996-11-15 | 2000-05-09 | Avi Biopharma, Inc. | Reagent and method for isolation and detection of selected nucleic acid sequences |
US5783567A (en) * | 1997-01-22 | 1998-07-21 | Pangaea Pharmaceuticals, Inc. | Microparticles for delivery of nucleic acid |
-
1999
- 1999-12-08 SE SE9904475A patent/SE9904475D0/sv unknown
-
2000
- 2000-12-07 US US10/149,458 patent/US20030166594A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030166594A1 (en) | 2003-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9904475D0 (sv) | Nucleic acid delivery system | |
Drews et al. | Function, structure and composition of cell walls and external layers | |
Loeb et al. | Phosphorylation of some rat liver ribosomal proteins and its activation by cyclic AMP | |
Bhatt et al. | Chemical pathways of peptide degradation. I. Deamidation of adrenocorticotropic hormone | |
KR960703620A (ko) | 면역 보조제로서 포스파젠 고분자 전해질(phosphazene polyelectrolytes as immunoadjuvants) | |
WO1997042975A3 (en) | Chitosan related compositions for delivery of nucleic acids into a cell | |
SE9801288D0 (sv) | Vaccine delivery system and metod of production | |
UA42089C2 (uk) | Протигрипозна вакцина на основі поверхневого антигену, спосіб її виробництва | |
IL133710A0 (en) | Improved method for transferring nucleic acid into the striped muscle and combination thereof | |
SE8901672D0 (sv) | System foer avgivning av en substans med biologisk eller farmakologisk verkan | |
NZ336718A (en) | Biodegradable targetable microparticle delivery system containing a polymer comprising alpha-hydroxy acids and/or pseudo alpha-amino acids | |
BRPI0416032A (pt) | excipientes em veìculos de distribuição de fármacos | |
TR200103149T2 (tr) | Virüs ve mikoplazmanın korunması için yöntemler | |
US4013788A (en) | Watersoluble extracts of corynebacteria, process for obtaining them and their use | |
WO2005055980A3 (en) | Polymalic acid-based multifunctional drug delivery system | |
MXPA02005697A (es) | Sistema de suministro de acido nucleico. | |
ATE203997T1 (de) | Antiwachstumwirksame proteine aus oozyten von rana pipiens | |
CN111249469B (zh) | 一种能够溶酶体逃逸的肽纳米颗粒及其制备方法和应用 | |
WO2004009112A8 (en) | Use of urease for inhibiting cancer cell growth | |
CN104906075A (zh) | 共递送纳米载体及其制备方法 | |
CN101381454A (zh) | 离子型温度响应性超支化聚醚和/或聚醚酯的制备方法 | |
Stebbing | Cellular uptake and in vivo fate of polynucleotides | |
FR2768747B1 (fr) | Acides nucleiques, cellules recombinantes, et procede de preparation de compositions immunogenes | |
JP2005247967A (ja) | 高分子電解質複合体およびその製造方法 | |
KUŽELA et al. | Formation, size, and solubility in chloroform/methanol of products of protein synthesis in isolated mitochondria of rat liver and Zajdela hepatoma |